Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 10, 2008, Pages 3885-3890

  Wadsworth, Jonathan D F ^a   Joiner, Susan ^a   Linehan, Jacqueline M ^a   Desbruslais, Melanie ^a   Fox, Katie ^a   Cooper, Sharon ^a   Cronier, Sabrina ^a   Asante, Emmanuel A ^a   Mead, Simon ^a   Brandner, Sebastian ^a   Hill, Andrew F ^a,b   Collinge, John ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Iatrogenic CJD; Transmissible spongiform encephalopathy; Variant CJD

Indexed keywords

PRION PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; IATROGENIC DISEASE; KURU; MOUSE; NEUROPATHOLOGY; NONHUMAN; PAPUA NEW GUINEA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; WILD TYPE; ANIMAL; BRAIN; HUMAN; IMMUNOBLOTTING; METABOLISM; PATHOLOGY; PHENOTYPE; PRION;

MUS; MUS MUSCULUS;

ANIMALS; BRAIN; CREUTZFELDT-JAKOB SYNDROME; HUMANS; IMMUNOBLOTTING; KURU; MICE; MICE, TRANSGENIC; PHENOTYPE; PRIONS; PRPSC PROTEINS;

EID: 41649086573     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0800190105     Document Type: Article

References (84)

1. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95:13363-13383.
2. Collinge J (2001) Prion diseases of humans and animals: Their causes and molecular basis. Annu Rev Neurosci 24:519-550.
3. Weissmann C (2004) The state of the prion. Nat Rev Microbiol 2:861-871.
4. Collinge J (2005) Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 76:906-919.
5. Wadsworth JDF, Collinge J (2007) Update on human prion disease. Biochim Biophys Acta 1772:598-609.
6. Bruce ME, Fraser H, McBride PA, Scott JR, Dickinson AG (1992) in Prion Diseases in Human and Animals, eds Prusiner SB, Collinge J, Powell J, Anderton B (Ellis Horwood, London), pp 497-508.
7. Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859-7868.
8. Telling GC, et al. (1996) Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 274:2079-2082.
9. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383:685-690.
10. Parchi P, et al. (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob Disease. Ann Neurol 39:767-778.
11. Parchi P, et al. (1999) Classification of sporadic Creutzfeldt-Jakob Disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224-233.
12. Safar J, et al. (1998) Eight prion strains have PrPSc molecules with different conformations. Nat Med 4:1157-1165.
13. Hill AF, Collinge J (2003) Subclinical prion infection. Trends Microbiol 11:578-584.
14. Asante EA, et al. (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21:6358-6366.
15. Wadsworth JDF, et al. (2004) Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 306:1793-1796.
16. Stephenson DA, et al. (2000) Quantitative trait loci affecting prion incubation time in mice. Genomics 69:47-53.
17. Lloyd SE, et al. (2001) Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci USA 98:6279-6283.
18. Lloyd SE, et al. (2004) Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. J Gen Virol 85:2471-2478.
19. Zigas V, Gajdusek DC (1959) Kuru: Clinical, pathological and epidemiological study of a recently discovered acute progressive degenerative disease of the central nervous system reaching epidemic proportions among natives of the Eastern Highlands of New Guinea. PNG Med J 3:1-31.
20. Alpers MP (1987) in Prions: Novel Infectious Pathogens Causing Scrapie and Creutzfeldt-Jakob Disease, eds Prusiner SB, McKinley MP (Academic, San Diego), pp 451-465.
21. Collinge J, Palmer MS (1997) Prion Diseases (Oxford Univ Press, Oxford).
22. Mead S, et al. (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300:640-643.
23. Collinge J, et al. (2006) Kuru in the 21st century-an acquired human prion disease with very long incubation periods. Lancet 367:2068-2074.
24. Gajdusek DC, Gibbs CJ, Jr, Alpers MP (1966) Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209:794-796.
25. Will RG, et al. (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347:921-925.
26. Hill AF, et al. (1997) The same prion strain causes vCJD and BSE. Nature 389:448-450.
27. Bruce ME, et al. (1997) Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389:498-501.
28. Collinge J (1999) Variant Creutzfeldt-Jakob disease. Lancet 354:317-323.
29. Wadsworth JDF, et al. (2001) Tissue distribution of protease resistant prion protein in variant CJD using a highly sensitive immuno-blotting assay. Lancet 358:171-180.
30. Llewelyn CA, et al. (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417-421.
31. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527-529.
32. Wroe SJ, et al. (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: A case report. Lancet 368:2061-2067.
33. Wadsworth JDF, et al. (2006) Prion infectivity in vCJD rectum. Gut 56:90-94.
34. Hilton DA, et al. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203:733-739.
35. Frosh A, et al. (2004) Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein Lancet 364:1260-1262.
36. Hilton DA (2005) Pathogenesis and prevalence of variant Creutzfeldt-Jakob disease. J Pathol 208:134-141.
37. Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337:1441-1442.
38. Palmer MS, Dryden AJ, Hughes JT, Collinge J (1991) Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature 352:340-342.
39. Windl O, et al. (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: A systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98:259-264.
40. Lee HS, et al. (2001) Increased susceptibility to kuru of carriers of the PRNP 129 methionine/methionine genotype. J Infect Dis 183:192-196.
41. Collins SJ, et al. (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129:2278-2287.
42. Alpers MP (2005) The epidemiology of kuru in the period 1987 to 1995. Commun Dis Intell 29:391-399.
43. Alpers M, Rail L (1971) Kuru and Creutzfeldt-Jakob disease: Clinical and aetiological aspects. Proc Aust Assoc Neurol 8:7-15.
44. Brown P, et al. (1994) Human spongiform encephalopathy: The National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513-529.
45. Wadsworth JDF, et al. (1999) Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol 1:55-59.
46. Hill AF, et al. (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:1333-1346.
47. Hill AF, et al. (2006) Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Brain 129:676-685.
48. Wadsworth JDF, et al. (2006) Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain 129:1557-1569.
49. Parchi P, et al. (1997) Typing prion isoforms. Nature 386:232-233.
50. Parchi P, et al. (2000) Genetic influence on the structural variations of the abnormal prion protein. Proc Natl Acad Sci USA 97:10168-10172.
51. Collinge J, et al. (1995) Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378:779-783.
52. Lloyd SE, et al. (2004) Identification and characterization of a novel mouse prion gene allele. Mamm Genome 15:383-389.
53. Hill AF, Collinge J (2001) Strain variations and species barriers. Contrib Microbiol 7:48-57.
54. Asante EA, et al. (2006) Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc Natl Acad Sci USA 103:10759-10764.
55. Collinge J, et al. (1992) Inherited prion disease with 144 base pair gene insertion: II: Clinical and pathological features. Brain 115:687-710.
56. Wadsworth JDF, Hill AF, Beck JA, Collinge J (2003) Molecular and clinical classification of human prion disease. Br Med Bull 66:241-254.
57. Ironside JW, Head MW (2004) Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 284:133-159.
58. McLean CA, et al. (1998) Comparative neuropathology of kuru with the new variant Creutzfeldt-Jakob disease: Evidence for a strain of agent predominating over genotype of host. Brain Pathol 8:429-437.
59. Hainfellner JA, et al. (1997) Pathology and immunocytochemistry of a kuru brain. Brain Pathol 7:547-553.
60. Budka H (2003) Neuropathology of prion diseases. Br Med Bull 66:121-130.
61. Billette de Villemeur T, et al. (1994) Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: A neuropathological study. Neuropathol Appl Neurobiol 20:111-117.
62. Brown P, Preece MA, Will RG (1992) "Friendly fire" in medicine: Hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 340:24-27.
63. Brown P, et al. (2000) Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075-1081.
64. Brown P, Brandel JP, Preese M, Sato T (2006) Iatrogenic Creutzfeldt-Jakob disease. The waning of an era. Neurology 67:389-393.
65. Will RG (2003) Acquired prion disease: Iatrogenic CJD, variant CJD, kuru. Br Med Bull 66:255-265.
66. Brown P, Cathala F, Raubertas RF, Gajdusek DC, Castaigne P (1987) The epidemiology of Creutzfeldt-Jakob disease: Conclusion of a 15-year investigation in France and review of the world literature. Neurology 37:895-904.
67. Mead S, et al. (2007) Inherited prion disease with 5-OPRI: Phenotype modification by repeat length and codon 129. Neurology 69:730-738.
68. Pocchiari M, et al. (2004) Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 127:2348-2359.
69. Mead S, et al. (2006) Inherited prion disease with six octapeptide repeat insertional mutation-molecular analysis of phenotypic heterogeneity. Brain 129:2297-2317.
70. Murray K, et al. (2007) Sporadic Creutzfeldt-Jakob disease in two adolescents. J Neurol Neurosurg Psychiatry 79:14-18.
71. Hill AF, Zeidler M, Ironside J, Collinge J (1997) Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349:99-100.
72. Hill AF, et al. (1999) Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353:183-189.
73. Glatzel M, Abela E, Maissen M, Aguzzi A (2003) Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N Engl J Med 349:1812-1820.
74. Hilton DA, et al. (2004) Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 57:300-302.
75. Head MW, et al. (2004) Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: An immunohistochemical, quantitative, and biochemical study. Am J Pathol 164:143-153.
76. Joiner S, Linehan JM, Brandner S, Wadsworth JDF, Collinge J (2005) High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease. Gut 54:1506-1508.
77. Budka H, et al. (1995) Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (Prion diseases). Brain Pathol 5:319-322.
78. Advisory Committee on Dangerous Pathogens (1998) Transmissible Spongiform Encephalopathy Agents: Safe Working and the Prevention of Infection (HM Stationary Office, London).
79. Kascsak RJ, et al. (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688-3693.
80. Piccardo P, et al. (1998) An antibody raised against a conserved sequence of the prion protein recognizes pathological isoforms in human and animal prion diseases, including Creutzfeldt-Jakob disease and bovine spongiform encephalopathy. Am J Pathol 152:1415-1420.
81. Serban D, Taraboulos A, DeArmond SJ, Prusiner SB (1990) Rapid detection of Creutzfeldt-Jakob disease and scrapie prion proteins. Neurology 40:110-117.
82. Telling GC, et al. (1994) Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci USA 91:9936-9940.
83. Bueler H, et al. (1992) Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582.
84. Carlson GA, et al. (1986) Linkage of prion protein and scrapie incubation time genes. Cell 46:503-511.